Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin Chao

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Breast Cancer|April 24, 2016
The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong KongRoland C Y Leung, Thomas C C Yau, Miranda C M Chan, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
NPJ Precision Oncology|October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncologyHenry Hiep Vo, Siqing Fu, David S Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancerRiley E Bergman, Christin I Keeton, Irika R Sinha, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Breast Cancer|April 24, 2016
The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong KongRoland C Y Leung, Thomas C C Yau, Miranda C M Chan, et al.
JCO Global Oncology|September 10, 2021
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin AmericaHenry L Gomez, Juan E Bargallo-Rocha, Roberto J Billinghurst, et al.
NPJ Precision Oncology|October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncologyHenry Hiep Vo, Siqing Fu, David S Hong, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancerRiley E Bergman, Christin I Keeton, Irika R Sinha, et al.
Pageof 4